Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer.
暂无分享,去创建一个
K. Yamashita | Takatoshi Nakamura | H. Katoh | H. Ozawa | K. Hatate | A. Ihara | Y. Kokuba | Wataru Onozato | T. Satoh | M. Watanabe
[1] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Fietkau,et al. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Ychou,et al. Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting , 2008, Oncology.
[4] D. Cunningham,et al. Adjuvant chemotherapy of colorectal cancer , 2007, The Lancet.
[5] J. Roh,et al. Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases , 2007, Oncology Research and Treatment.
[6] K. Yamashita,et al. Surgical resection of stage IV gastric cancer and prognosis. , 2007, Anticancer research.
[7] K. Yamashita,et al. Transfusion Alert for Patients with Curable Cancer , 2007, World Journal of Surgery.
[8] A. Stewart,et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. , 2005, JAMA.
[9] F. Momm,et al. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9. , 2005, Anticancer research.
[10] Shung-Haur Yang,et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? , 2005, The Journal of surgical research.
[11] C. Ko,et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.
[12] M. Buyse,et al. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Gonen,et al. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Daniel J Sargent,et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.
[15] F. Cruz,et al. Use of the preoperative levels of CEA in patients with colorectal cancer. , 2003, Hepato-gastroenterology.
[16] M. Duffy,et al. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? , 2001, Clinical chemistry.
[17] L. Saltz,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.
[18] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.
[19] C. Boland,et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil. , 1999, Gastroenterology.
[20] J. Guillem,et al. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. , 1997, Journal of the American College of Surgeons.
[21] S. Cha,et al. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. , 1987, Archives of surgery.
[22] R. G. Hoffman,et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. , 1978, The New England journal of medicine.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[24] R. Schilsky,et al. A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903 , 2009, Annals of Surgical Oncology.
[25] J W Arends,et al. Regression analysis of prognostic factors in colorectal cancer after curative resections , 1988, Diseases of the colon and rectum.
[26] D. Cox. Regression Models and Life-Tables , 1972 .